ELEV Elevation Oncology, Inc.: Bozor kapitallashuvining balans qiymatiga nisbati
Elevation Oncology uchinchi tomon laboratoriyalari orqali ishlanmalarni virtuallashtirish yo'li bilan xarajatlarni minimallashtiradi. Bozor kapitalizatsiyasining kitob kapitalizatsiyasiga nisbati koeffitsienti ushbu modelni aks ettiradi, bunda 0.47 belgisi joriy holatni ko'rsatadi. Kotsirovkalar makrosikllarni e'tiborga olmaydi, buning o'rniga testlarning muvaffaqiyatiga tayanadi. Joriy narx potentsiali savdolarning yo'qligi bilan cheklangan va eksklyuziv ravishda kelgusidagi patentlarga bog'liq.
%20-%20Kapitallashuvning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ELEV_-_Elevation-Oncology_-_Market-Cap-to-Net-Assets-Ratio "ELEV Elevation Oncology, Inc. Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 02.08.2025) | 👁️GURU.Markets👁️")
ELEV (Elevation Oncology Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Elevation Oncology|ELEV - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Elevation Oncology|ELEV - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Elevation Oncology|ELEV - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Elevation Oncology
Fundamental baholash:ELEV (Elevation Oncology, Inc.)
Uzoq muddatli investor uchun Elevation Oncology (ELEV) ishonchliligi uning kapitalni boshqarish samaradorligi bilan belgilanadi. Ushbu koeffitsient biznesning joriy bozor qiymatini uning sof aktivlariga solishtirib, kelajakdagi o'sish uchun qo'shimcha qiymatni namoyish etadi. Bozor baholovishining kitob qiymatiga nisbatan tarixini tahlil qilish autsorsing modelining ta'sirini ochib beradi. Shaxsiy ishlab chiqarish zavodlarining yo'qligi balansdagi aktivlarni minimallashtiradi, bu esa tabiiy ravishda multiplikatorni oshiradi. Bunday tuzilma kompaniyaning moslashuvchanligini tasdiqlaydi.
Asosiy raqobatchilar
BeiGene Ltd (ONC) - Kapitallashuvning sof aktivlarga nisbati|halozyme.com (HALO) - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati YMAB|AURA (Aura Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CADL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati accuray.com (ARAY)|SELLAS Life Sciences (SLS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|HURA - Kapitallashuvning sof aktivlarga nisbati|Protara Therapeutics - Kapitallashuvning sof aktivlarga nisbati|FATE: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati aadibio.com WHWK|TScan Therapeutics, Inc. (TCRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CSBR (Champions Oncology Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBiotech USA|CEL-SCI Corporation - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti OSTX (ostherapies.com)|Bozor qiymatining balans qiymatiga nisbati Radiopharm Theranostics RADX|Bozor qiymatining balans qiymatiga nisbati Artiva Biotherapeutics Inc. ARTV|ANL (Adlai Nortye Limited) - Bozor kapitallashuvining balans qiymatiga nisbati|Veru Corporation (VERU) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Tempest Therapeutics (TPST) - Kapitallashuvning sof aktivlarga nisbati|Xilio Therapeutics (XLO) - Bozor qiymatining balans qiymatiga nisbati|RENB (Renovaro Biosciences) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Mural Bio (MURA)|Kapitallashuvning sof aktivlarga nisbati Kairos Pharma Ltd|Bozor kapitallashuvining balans qiymatiga multiplikatori onkuretherapeutics.com (OKUR)|Bozor kapitallashuvining balans qiymatiga nisbati GDTC|Curis Inc. - Balans qiymatiga nisbatan bozor kapitallashuvi|APLM (Apollomics Corp) - Bozor qiymatining balans qiymatiga nisbati|THAR: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati advanbiomed.com|Kapitallashuvning balans qiymatiga nisbati Genprex Inc|CLDI - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati SBFM|Xenetic Biosciences - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti SLRX (Salarius Pharmaceuticals Inc)|PPBT - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati American Oncology Network Inc AONC|BGNE: Bozor kapitallashuvining balans qiymatiga nisbati|CKPT: Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati ICAD|IKNA (Ikena Oncology) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Notable Labs Inc.|Bozor qiymatining balans qiymatiga nisbati VIRX|MorphoSys AG - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti nayabiosciences.com (NAYA)|AAPGV (Ascentage Pharma) - Bozor kapitallashuvining balans qiymatiga nisbati